Drugs & OTC

MMJ Group Holdings Ltd (ASX:MMJ) CEO Resignation

🕔2/4/2019 8:55:20 AM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) announces that its Chief Executive Officer Mr Jason Conroy has tendered his resignation.

Read Full Article

THC Global Group Limited (ASX:THC) Corporate Update - January 2019

🕔1/31/2019 4:42:11 PM

THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update on the Company's activities as it transitions into full-scale domestic operations having secured almost all licencing and permitting required for its vertically integrated, Farm to Pharma business model.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

🕔1/30/2019 11:03:48 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2018. The Company's cash position at the end of the quarter stood at $1.5m. The Company also had $4,500,000 in deposits with terms of greater than 90 days. Expenditure during the quarter was in line with forecast.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Harvest One (CVE:HVT) Launches Satipharm Reformulated CBD Capsules in Europe

🕔1/30/2019 9:57:13 AM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached announcement by Harvest One Cannabis Inc. (CVE:HVT) (OTCMKTS:HRVOF) confirming that it has launched European sales of its recently reformulated Satipharm CBD capsules.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Portfolio Update

🕔1/29/2019 1:16:32 PM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to provide an update on the unaudited market value of its investment portfolio (as at 29 January 2019).

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) General Meeting and Share Purchase Plan

🕔1/23/2019 9:12:26 AM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) has issued the attached notice to hold a meeting of MMJ shareholders on 22 February 2019 to approve, amongst other things, the launch of a share purchase plan ("SPP") as announced on 19 December 2018.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Non-Executive Director Appointment

🕔1/23/2019 8:21:56 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce the appointment of Dr. David Brookes as Non-Executive Director and Chair of the Audit and Risk Committee, effective from 23 January 2019.

Read Full Article